Urinary epidermal growth factor in kidney disease: A systematic review Mónica Ríos-Silva, Miguel Huerta, Oliver Mendoza-Cano, Efrén Murillo-Zamora, Yolitzi Cárdenas, Jaime Alberto Bricio-Barrios, Yunuem Diaz, Isabel Ibarra, Xóchitl Trujillo

Telomerase activity in patients with stage 2–5D chronic kidney disease Veysel Kidir, Ayse Aynali, Atila Altuntas, Salih Inal, Buket Aridogan, Mehmet Tugrul Sezer

Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto, Haerani Rasyid, Anastasya Angelica Vicente, Winny Suciangto